List of bibliographic references
Number of relevant bibliographic references: 15.
| Ident. | Authors (with country if any) | Title |
|---|
| 000A19 (2019) |
Shino Fujimoto [Japon] ; Tomoyuki Sakai [Japon] ; Hiroshi Kawabata [Japon] ; Nozomu Kurose [Japon] ; Sohsuke Yamada [Japon] ; Mariko Doai [Japon] ; Munetaka Matoba [Japon] ; Haruka Iwao-Kawanami [Japon] ; Takafumi Kawanami [Japon] ; Shuichi Mizuta [Japon] ; Toshihiro Fukushima [Japon] ; Hiroki Mizumaki [Japon] ; Masaki Yamaguchi [Japon] ; Yasufumi Masaki [Japon] | Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease |
| 000C98 (2019) |
Yasufumi Masaki ; Hiroshi Kawabata ; Shino Fujimoto ; Mitsuhiro Kawano ; Noriko Iwaki ; Takeharu Kotani ; Akikatsu Nakashima ; Nozomu Kurose ; Kazue Takai ; Ritsuro Suzuki ; Sadao Aoki | Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan |
| 001A31 (2016) |
Sumie Hiramatsu ; Koichiro Ohmura ; Hideaki Tsuji ; Hiroshi Kawabata ; Toshiyuki Kitano ; Ayuko Sogabe ; Motomu Hashimoto ; Kosaku Murakami ; Yoshitaka Imura ; Naoichiro Yukawa ; Hajime Yoshifuji ; Takao Fujii ; Akifumi Takaori-Kondo ; Tsuneyo Mimori | Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. |
| 001A81 (2016) |
Yasufumi Masaki ; Hiroshi Kawabata ; Kazue Takai ; Norifumi Tsukamoto ; Shino Fujimoto ; Yasuhito Ishigaki ; Nozomu Kurose ; Masaru Kojima ; Shigeo Nakamura ; Tomohiro Kinoshita ; Sadao Aoki | Proposed diagnostic criteria, disease severity classification, and treatment strategy for a novel disorder; TAFRO syndrome. |
| 001A82 (2016) |
Yasufumi Masaki [Japon] ; Hiroshi Kawabata [Japon] ; Kazue Takai [Japon] ; Masaru Kojima [Japon] ; Norifumi Tsukamoto [Japon] ; Yasuhito Ishigaki [Japon] ; Nozomu Kurose [Japon] ; Makoto Ide [Japon] ; Jun Murakami [Japon] ; Kenji Nara [Japon] ; Hiroshi Yamamoto [Japon] ; Yoko Ozawa [Japon] ; Hidekazu Takahashi [Japon] ; Katsuhiro Miura [Japon] ; Tsutomu Miyauchi [Japon] ; Shinichirou Yoshida [Japon] ; Akihito Momoi [Japon] ; Nobuyasu Awano [Japon] ; Soichiro Ikushima [Japon] ; Yasunori Ohta [Japon] ; Natsue Furuta [Japon] ; Shino Fujimoto [Japon] ; Haruka Kawanami [Japon] ; Tomoyuki Sakai [Japon] ; Takafumi Kawanami [Japon] ; Yoshimasa Fujita [Japon] ; Toshihiro Fukushima [Japon] ; Shigeo Nakamura [Japon] ; Tomohiro Kinoshita [Japon] ; Sadao Aoki [Japon] | Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. |
| 002419 (2014) |
Motomu Hashimoto [Japon] ; Takao Fujii [Japon] ; Masahide Hamaguchi [Japon] ; Moritoshi Furu [Japon] ; Hiromu Ito [Japon] ; Chikashi Terao [Japon] ; Keiichi Yamamoto [Japon] ; Wataru Yamamoto [Japon] ; Takashi Matsuo [Japon] ; Masato Mori [Japon] ; Koichiro Ohmura [Japon] ; Hiroshi Kawabata [Japon] ; Tsuneyo Mimori [Japon] | Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. |
| 002710 (2013) |
Hiroshi Kawabata [Japon] ; Shin-Ichi Kotani ; Yumi Matsumura ; Tadakazu Kondo ; Tatsuya Katsurada ; Hironori Haga ; Norimitsu Kadowaki ; Akifumi Takaori-Kondo | Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. |
| 002810 (2013) |
Soken-Nakazawa J. Song ; Mitsuhiro Iwahashi ; Naohisa Tomosugi ; Kazuko Uno ; Jiro Yamana ; Seizou Yamana ; Tomoyasu Isobe ; Hiroki Ito ; Hiroshi Kawabata ; Kazuyuki Yoshizaki | Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients. |
| 002815 (2013) |
Hiroshi Kawabata [Japon] ; Norimitsu Kadowaki ; Momoko Nishikori ; Toshio Kitawaki ; Tadakazu Kondo ; Takayuki Ishikawa ; Hajime Yoshifuji ; Noriyuki Yamakawa ; Yoshitaka Imura ; Tsuneyo Mimori ; Yumi Matsumura ; Yoshiki Miyachi ; Takeshi Matsubara ; Motoko Yanagita ; Hironori Haga ; Akifumi Takaori-Kondo | Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. |
| 002821 (2013) |
Hiroshi Kawabata [Japon] ; Kazue Takai ; Masaru Kojima ; Naoya Nakamura ; Sadao Aoki ; Shigeo Nakamura ; Tomohiro Kinoshita ; Yasufumi Masaki | Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). |
| 003D21 (2010) |
Soken-Nakazawa J. Song [Japon] ; Naohisa Tomosugi ; Hiroshi Kawabata ; Takayuki Ishikawa ; Teppei Nishikawa ; Kazuyuki Yoshizaki | Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. |
| 003F35 (2010) |
Soken-Nakazawa J. Song [Japon] ; Naohisa Tomosugi [Japon] ; Hiroshi Kawabata [Japon] ; Takayuki Ishikawa [Japon] ; Teppei Nishikawa [Japon] ; Kazuyuki Yoshizaki [Japon] | Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease |
| 004248 (2007) |
Junya Kanda [Japon] ; Hiroshi Kawabata ; Yuhei Yamaji ; Tatsuo Ichinohe ; Takayuki Ishikawa ; Toshihiro Tamura ; Yutaka Furukawa ; Takeshi Kimura ; Toru Kita ; Takashi Uchiyama | Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody. |
| 004264 (2007) |
Hiroshi Kawabata ; Naohisa Tomosugi ; Junya Kanda ; Yasuhiro Tanaka ; Kazuyuki Yoshizaki ; Takashi Uchiyama | Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. |
| 004300 (2007) |
Junya Kanda [Japon] ; Hiroshi Kawabata [Japon] ; Yuhei Yamaji [Japon] ; Tatsuo Ichinohe [Japon] ; Takayuki Ishikawa [Japon] ; Toshihiro Tamura [Japon] ; Yutaka Furukawa [Japon] ; Takeshi Kimura [Japon] ; Toru Kita [Japon] ; Takashi Uchiyama [Japon] | Reversible cardiomyopathy associated with multicentric castleman disease : Successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Hiroshi Kawabata"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i \
-Sk "Hiroshi Kawabata" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Merge
|type= indexItem
|index= Author.i
|clé= Hiroshi Kawabata
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
